Biogen Stock One of the Best to Own Next Week

BIIB calls have been popular in recent weeks

May 24, 2019 at 10:55 AM
facebook twitter linkedin

Biogen Inc (NASDAQ:BIIB) stock suffered its worst day in 14 years on March 21, when it gapped 29.2% lower on a pair of halted Alzheimer's disease drug trials. The shares have since struggled to surpass these bear gap levels below $235 -- last seen up 0.4% at $230.13 -- but some short-term upside could be in the cards, if history is any guide.

 According to data from Schaeffer's Senior Quantitative Analyst Rocky White, BIIB has been one of the best stocks to own on the S&P 500 Index (SPX) during the Memorial Day week, looking back 10 years. Specifically, the drugmaker has averaged a 1.7% gain over the holiday-shortened period, with eight of those returns positive.

Options traders have been betting on a bounce for Biogen. At the International Securities Exchange (ISE), Chicago Board Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX), the stock's 10-day call/put volume ratio of 2.66 ranks in the 90th annual percentile, meaning calls have been bought to open over puts at a faster-than-usual pace.

Given the stock's recent struggles, it's possible shorts are using long calls to guard against any upside risk. Short interest jumped 11.3% in the two most recent reporting periods to 3.96 million shares, though this still accounts for a low 2% of BIIB's float.

biogen stock daily price chart on may 24


Now is the time to join our thriving community of Event Traders who consistently profit from every earnings season. With this discounted subscription opportunity, you'll stay ahead of the curve and seize opportunities others miss. Do not let Q3 earnings season pass you by – subscribe now and supercharge your portfolio with expert insights that turn market reactions into profit-generating opportunities!! Don't waste another second... join us right now before the next trade targeting +200% is released!